Steven Cohen Legend Biotech Corp Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
Shares
6 transactions
Others Institutions Holding LEGN
# of Institutions
233Shares Held
86.1MCall Options Held
260KPut Options Held
387K-
Ra Capital Management, L.P. Boston, MA7.51MShares$277 Million3.96% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.81MShares$252 Million0.03% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$221 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$211 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.71MShares$211 Million0.86% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.19B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...